Point Tech has sublicensed two US patents which are directed to a method of making a nucleic acid array by tapping the tip of a dispensing device against a solid support
Point Technologies and Incyte announce an agreement under which Point Tech has sublicensed two US patents which are directed to a method of making a nucleic acid array by tapping the tip of a dispensing device against a solid support.
The license agreement will allow direct end users to buy and use Point Tech Accelerator split spotting pins for internal research purposes.
It will also allow robotic microarrayer manufacturers to offer the Accelerator split pins for sale to their customers for the same end.
Kirk O'Brien, Point Technologies's president, said "We are extremely pleased to sign this agreement with Incyte as it establishes Point Tech as the first microarray spotting pin manufacturer to sublicense the basic technology patents for nucleic acid contact printing".
"We have patents pending on our innovative radiused tip split spotting pin and we have unique product offerings in solid pins.
Our innovative use of tungsten instead of stainless steel, colour-coded and sequentially numbered collars and more user-friendly packaging have been recognized by the market as needed and welcome changes", added O'Brien.
Point Technologies uses precision electrochemical etching technology to manufacture tungsten spotting split and solid spotting pins.
Accelerator brand slit spotting pins.
The company's products are used by companies in the semiconductor industry, which incorporate the probe needles in probe cards, which are then sold to chip manufacturers such as Intel, Motorola, TI and IBM.
Point Tech also makes a wide variety of needles, pins and electrodes, including electrosurgery electrodes for the medical device industry.
The relevant patents are US Patent 5,807,522 'Methods for Fabricating Microarrays of Biological Samples' issued 15 September 1998 and US Patent 6,110,426 'Methods for Fabricating Microarrays of Biological Samples' issued 29 August 2000.